Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Nature ; 593(7859): 418-423, 2021 05.
Artigo em Inglês | MEDLINE | ID: mdl-33727703

RESUMO

The COVID-19 pandemic is the third outbreak this century of a zoonotic disease caused by a coronavirus, following the emergence of severe acute respiratory syndrome (SARS) in 20031 and Middle East respiratory syndrome (MERS) in 20122. Treatment options for coronaviruses are limited. Here we show that clofazimine-an anti-leprosy drug with a favourable safety profile3-possesses inhibitory activity against several coronaviruses, and can antagonize the replication of SARS-CoV-2 and MERS-CoV in a range of in vitro systems. We found that this molecule, which has been approved by the US Food and Drug Administration, inhibits cell fusion mediated by the viral spike glycoprotein, as well as activity of the viral helicase. Prophylactic or therapeutic administration of clofazimine in a hamster model of SARS-CoV-2 pathogenesis led to reduced viral loads in the lung and viral shedding in faeces, and also alleviated the inflammation associated with viral infection. Combinations of clofazimine and remdesivir exhibited antiviral synergy in vitro and in vivo, and restricted viral shedding from the upper respiratory tract. Clofazimine, which is orally bioavailable and comparatively cheap to manufacture, is an attractive clinical candidate for the treatment of outpatients and-when combined with remdesivir-in therapy for hospitalized patients with COVID-19, particularly in contexts in which costs are an important factor or specialized medical facilities are limited. Our data provide evidence that clofazimine may have a role in the control of the current pandemic of COVID-19 and-possibly more importantly-in dealing with coronavirus diseases that may emerge in the future.


Assuntos
Antivirais/farmacologia , Clofazimina/farmacologia , Coronavirus/classificação , Coronavirus/efeitos dos fármacos , SARS-CoV-2/efeitos dos fármacos , Monofosfato de Adenosina/análogos & derivados , Monofosfato de Adenosina/farmacologia , Monofosfato de Adenosina/uso terapêutico , Alanina/análogos & derivados , Alanina/farmacologia , Alanina/uso terapêutico , Animais , Anti-Inflamatórios/farmacocinética , Anti-Inflamatórios/farmacologia , Anti-Inflamatórios/uso terapêutico , Antivirais/farmacocinética , Antivirais/uso terapêutico , Disponibilidade Biológica , Fusão Celular , Linhagem Celular , Clofazimina/farmacocinética , Clofazimina/uso terapêutico , Coronavirus/crescimento & desenvolvimento , Coronavirus/patogenicidade , Cricetinae , DNA Helicases/antagonistas & inibidores , Sinergismo Farmacológico , Feminino , Humanos , Estágios do Ciclo de Vida/efeitos dos fármacos , Masculino , Mesocricetus , Profilaxia Pré-Exposição , SARS-CoV-2/crescimento & desenvolvimento , Especificidade da Espécie , Glicoproteína da Espícula de Coronavírus/antagonistas & inibidores , Transcrição Gênica/efeitos dos fármacos , Transcrição Gênica/genética
2.
Nihon Hansenbyo Gakkai Zasshi ; 73(3): 245-51, 2004 Sep.
Artigo em Japonês | MEDLINE | ID: mdl-15508727

RESUMO

Multinucleated giant cells (MGC) are characteristic cells in granulomatous disorders such as sarcoidosis and leprosy. There are two types of MGC; foreign body-type and Langhans-type cells. The exact mechanisms of the formation and the functional significance of MGC are not determined, although their morphological features are well understood. MGC are also formed in vitro from peripheral blood mononuclear cells by stimulation with cytokines and lectins. Particularly IFN-gamma is considered to play a pivotal role in monocyte fusion. IL-3, IL-4, IL-13, and GM-CSF are other reported cytokines involved in MGC formation. In addition to such inflammatory mediators, a factor derived from the pathogens of granulomatous disorders may be necessary for MGC formation. Muramyl dipeptide, a peptidoglycan portion of bacterial cell walls, is one of the candidates and can preferentially induce Langhans-type cells in in vitro MGC formation system. Although the exact mechanisms of in vitro MGC formation remains unknown, cell surface molecules such as P2X7 receptor, integrins, CD98, and macrophage fusion protein are considered to be involved in fusion process. Monocytes of sarcoidosis patients expressed higher levels of P2X7 and had a higher ability to induce MGC than those of healthy controls. Effective agents for sarcoidosis such as tranilast, alloprinol, and captopril inhibited in vitro MGC formation, suggesting their therapeutic effects through the direct effects on monocytes. Thus, an in vitro MGC formation model would be a useful tool to understand the relevance of MGC in granulomatous disorders.


Assuntos
Células Gigantes/patologia , Doença Granulomatosa Crônica/patologia , Monócitos/patologia , Acetilmuramil-Alanil-Isoglutamina , Animais , Fusão Celular , Citocinas/fisiologia , Proteína-1 Reguladora de Fusão/fisiologia , Humanos , Mediadores da Inflamação/fisiologia , Integrinas/fisiologia , Leucócitos Mononucleares/patologia , Macrófagos/patologia , Receptores Purinérgicos P2/fisiologia , Receptores Purinérgicos P2X7
3.
Proc Natl Acad Sci U S A ; 89(10): 4348-52, 1992 May 15.
Artigo em Inglês | MEDLINE | ID: mdl-1584768

RESUMO

Previously, we detected a subset of gamma delta T cells in the newborn mouse thymus that responded to the mycobacterial heat shock protein Hsp60, as well as with what seemed to be a self-antigen. All of these cells expressed V gamma 1, most often in association with V delta 6+. It was not clear, however, whether similar, mature gamma delta cells with Hsp60 reactivity are common outside of the thymus, or rather, whether they are largely eliminated during development. From the data presented here, we estimate that gamma delta cells responding to Hsp60 comprise 10-20% of normal splenic and lymph node gamma delta T cells. Such cells, derived from adult spleen, always express a V gamma 1-J gamma 4-C gamma 4 gamma chain, although not all cells with this gamma chain show Hsp60 reactivity. Many of these V gamma 1+ cells also express V delta 6-J delta 1-C delta, though fewer than in V gamma 1+ cells from the newborn thymus. Extensive diversity is evident in both the gamma and delta chain junctional amino acids of the receptors of these cells, indicating that they may largely develop in the thymus of older animals or undergo peripheral expansion. Finally, we found that all such cells responding to both a putative self-antigen and to mycobacterial Hsp60 respond to a 17-amino acid synthetic peptide representing amino acids 180-196 of the Mycobacterium leprae Hsp60 sequence. This report demonstrates that a large subset of Hsp60-reactive peripheral lymphoid gamma delta T cells preexists in normal adult mice, all members of which respond to a single segment of this common heat shock protein.


Assuntos
Genes de Imunoglobulinas , Proteínas de Choque Térmico/farmacologia , Região Variável de Imunoglobulina/genética , Mycobacterium leprae/imunologia , Peptídeos/farmacologia , Receptores de Antígenos de Linfócitos T/imunologia , Subpopulações de Linfócitos T/imunologia , Animais , Animais Recém-Nascidos , Anticorpos Monoclonais , Fusão Celular , Linhagem Celular , Proteínas de Choque Térmico/síntese química , Proteínas de Choque Térmico/imunologia , Hibridomas/imunologia , Interleucina-2/análise , Linfonodos/imunologia , Substâncias Macromoleculares , Camundongos , Camundongos Endogâmicos C57BL , Oligodesoxirribonucleotídeos , Peptídeos/síntese química , Peptídeos/imunologia , Reação em Cadeia da Polimerase/métodos , Receptores de Antígenos de Linfócitos T/genética , Baço/imunologia , Timo/imunologia , Transcrição Gênica
4.
Ann Immunol (Paris) ; 134C(3): 301-9, 1983.
Artigo em Inglês | MEDLINE | ID: mdl-6354064

RESUMO

Spleen cells from BALB/c mice infected two weeks earlier with Mycobacterium lepraemurium were fused with myeloma cells, and, using an indirect immunofluorescence assay, a hybridoma was selected which secreted ananti-M. lepraemurium IgM antibody. In the same assay, this monoclonal antibody also recognized 17 other species of Mycobacteria (including M. leprae) and two strains of Nocardia.


Assuntos
Anticorpos Antibacterianos/imunologia , Anticorpos Monoclonais/imunologia , Antígenos de Bactérias/imunologia , Infecções por Mycobacterium/imunologia , Animais , Anticorpos Antibacterianos/análise , Anticorpos Antibacterianos/biossíntese , Anticorpos Monoclonais/análise , Anticorpos Monoclonais/biossíntese , Especificidade de Anticorpos , Fusão Celular , Reações Cruzadas , Camundongos , Camundongos Endogâmicos BALB C , Mycobacterium lepraemurium/imunologia , Ratos , Baço/citologia
5.
J Gen Microbiol ; 89(2): 256-64, 1975 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-1176954

RESUMO

Ascus formation in Debaryomyces hansenii includes fusion of two cells, usually mother and daughter while still attached to each other, through short protuberances developed from the cross wall between them. Nuclear fusion takes place in the channel connecting the two cells; meiosis apparently occurs in the mother cell. Generally, only one lobe of the meiotic nucleus is surrounded by a prospore wall and it becomes the nucleus of a spore with a warty wall. The rest of the nucleus disappears. The spores germinate by swelling in the ascus and forming one or more buds.


Assuntos
Saccharomyces/crescimento & desenvolvimento , Fusão Celular , Membrana Celular/ultraestrutura , Núcleo Celular/ultraestrutura , Parede Celular/ultraestrutura , Conjugação Genética , Lipídeos , Meiose , Saccharomyces/ultraestrutura , Esporos Fúngicos/crescimento & desenvolvimento , Esporos Fúngicos/ultraestrutura
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA